New Delhi, 6th August 2025: Thyrocare Technologies Limited, a leading healthcare diagnostics company, has announced that its current Managing Director and Chief Executive Officer, Mr. Rahul Guha, will additionally assume the role of Managing Director and Chief Executive Officer of API Holdings Limited, the ultimate holding company of Thyrocare, effective from August 27, 2025.

Mr. Guha, while continuing in his current leadership role at Thyrocare, will also take on the additional responsibilities at API Holdings. His appointment reflects the group’s commitment to strengthening synergies across its portfolio and driving integrated growth.

The decision was made based on the recommendation of the Nomination and Remuneration Committee of API Holdings and was subsequently approved by its Board of Directors. With this development, the former Managing Director and Chief Executive Officer of API Holdings, Mr. Siddharth Shah, has been re-designated as Director and Vice Chairman of the company.

Mr. Guha previously served as President of Operations at API Holdings, where he played a key role in aligning operations across the API group of companies. In his expanded role, he will continue to focus on long-term growth and integration throughout the ecosystem while leading Thyrocare’s ongoing transformation and growth.

The post Rahul Guha additionally appointed as Managing Director and CEO of API Holdings appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

India, 4th December 2024: Thyrocare, a leading diagnostic and preventive healthcare provider in India, has released a comprehensive research report uncovering critical insights into the prevalence of diabetes and prediabetes across India. The study, which analyzed HbA1c test results from a staggering 1,966,449 adults nationwide undergoing a routine health check up in 2023, highlights alarming trends and regional disparities in the incidence of the disease. Key findings indicate that 49.43% of the tested population exhibited abnormal blood glucose levels, with 22.25% identified as prediabetic and 27.18% as diabetics. These statistics emphasize the growing burden of this metabolic disorder, positioning diabetes as a “pandemic in the making” and calling for urgent action.

Key Highlights of the Study

1. High Prevalence Across Regions
Odisha reported the highest prevalence of both prediabetes and diabetes, while Jammu & Kashmir recorded the lowest levels. This underscores the need for implementation of region-specific health programs to tackle the disparity. 

2. Dietary Patterns and Diabetes
The study revealed a striking correlation between dietary habits and diabetes prevalence. States with higher rice consumption showed a greater incidence of diabetes and prediabetes, while states with predominantly wheat-based diets demonstrated lower prevalence rates, highlighting the role of diet in managing disease risk. 

3. Gender and Age Trends

○      Males had a significantly higher diabetes prevalence (30.84%) compared to females (23.51%).

○      Prediabetes prevalence remained relatively balanced between genders.

○      The data shows highest diabetic burden in 65+ individuals, with worrying trends showing increasing prevalence in the economically active age group of 36-65 years. Young adults between 18-35 years show higher prevalence of prediabetes than diabetes, indicating a high potential to develop the disease.

4. Socioeconomic and Healthcare Challenges
The study warns of a severe strain on India’s healthcare infrastructure and individual finances, advocating for regular screening and awareness campaigns to mitigate the impact of undiagnosed cases. 

5. Screening Insights and Policy Implications
By leveraging HbA1c—a stable and reliable marker for long-term glucose monitoring—the research highlights the importance of routine testing. The findings urge policymakers to implement targeted preventive measures in high-burden regions, emphasizing lifestyle modifications and public health education. 

Mr. Rahul Guha, MD & CEO of Thyrocare Technologies Ltd. & President of API Holdings, commented: “This study sheds light on the silent but alarming rise of diabetes and prediabetes in India. With nearly half the tested population exhibiting abnormal glucose levels, it is imperative to prioritize regular testing, mass screening, and early detection. These efforts, combined with education and region-specific interventions, are crucial to curbing this epidemic. The role of diet in disease management cannot be understated, and we hope this research sparks meaningful action in public health policy and promotes a more proactive approach to disease prevention and management.”

Dr. Preet Kaur, Vice President – Lab Operations and Quality at Thyrocare Technologies Ltd. and a co-author of the study, stated, “This research provides a critical lens through which we can view the diabetes epidemic in India. The geographical and dietary trends revealed in this study demonstrate the significant impact of lifestyle on disease prevalence. Our goal with this research is to inspire not only greater public awareness but also stronger data-driven healthcare policies that prioritize early detection and preventive strategies.”

Thyrocare’s findings, published in the scientific journal – Diabetes Research and Clinical Practice, serve as a clarion call to combat diabetes through sustained efforts in education, lifestyle transformation, and universal screening programs.

The post Nearly 1 in 2 People Tested Exhibit Abnormal Blood Glucose Levels:  Thyrocare’s Research Report on Diabetes and Prediabetes in India appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.